S&P 500 7,704.13 −0.02%
Nasdaq 26,939.37 +0.01%
S&P/TSX 35,706.46 −0.13%
Apple 335.92 −0.33%
Nvidia 224.58 −0.41%
Microsoft 497.93 −0.53%
Shopify 205.30 +2.41%
Royal Bank 282.11 +0.27%
CAD/USD 0.7069 −0.29%
CLOSED · 23:55 ET
Market ClerkRecap
Thu Sep 24 · markets closed2 signals today167 insider buys this week · $225.2MCIRO short report next: Sep 30The week ahead
AE
INSIDER · RVMD · Revolution Medicines, Inc. · DIRECTOR

ANDERSON ELIZABETH M

Every open-market transaction filed under this name, Sep 22 to Sep 22.

Filings
5
0 buys · 5 sells
Bought
—
open market, at cost
Sold
$2M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 22RVMDRevolution Medicines, Inc.DirectorSell100$195.15$20K−2.3%
Sep 22RVMDRevolution Medicines, Inc.DirectorSell1,500$194.59$292K−2.0%
Sep 22RVMDRevolution Medicines, Inc.DirectorSell2,648$193.44$512K−1.4%
Sep 22RVMDRevolution Medicines, Inc.DirectorSell4,985$192.54$960K−0.9%
Sep 22RVMDRevolution Medicines, Inc.DirectorSell910$191.85$175K−0.6%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.